CARLSBAD, Calif.—GenMark Diagnostics Inc. and Advanced
Liquid Logic Inc. recently announced that they have entered into an agreement
defining the terms of a collaboration for the development of an all-electronic,
fully integrated in-vitro diagnostic
platform. The platform will combine Advanced Liquid Logic's proprietary electrowetting
technology and GenMark's proprietary electrochemical detection.

"This partnership will allow us to leverage both companies'
unique technologies and know-how to deliver a digital, sample-to-answer, in-vitro diagnostic platform. Our initial focus on multiplex
molecular testing will be followed by efforts in other areas of diagnostics
including protein detection and point-of-care testing, as we redefine industry
standards for performance, reliability and ease of use with even the most
complex of assays," Hany Massarany, president and CEO of GenMark, said in a
press release.